Filing Details

Accession Number:
0001911051-22-000003
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-29 21:57:10
Reporting Period:
2022-08-25
Accepted Time:
2022-08-29 21:57:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Aspira Women's Health Inc. AWH In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1911051 Rachelle Celeste Fralick C/O Aspira Women'S Health Inc.
12117 Bee Caves Rd, Bldg 3-100
Austin TX 78738
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-25 6,667 $0.00 102,945 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.001 Warrant (right to buy) Acquisiton 2022-08-25 6,667 $0.00 6,667 $0.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,667 2022-08-25 2027-08-25 No 4 P Direct
Footnotes
  1. Each share of common stock was purchased together with one warrant to purchase one share of common stock (each share and related warrant, a "unit"), at a price of $0.75 per unit.
  2. Total reflects the adjustment of 3,393 shares of common stock previously reported as part of a restricted stock unit grant made on March 31, 2022.